Stay Connected
Join us on Facebook Follow us on linked in Follow us on YouTube Follow us on Vimeo
Metabolic Drug Development
Diabetes - Metabolic Clinical Research

"We are pleased to align ourselves with this industry leader [Medpace] who is known to implement best practices. We look forward to beginning FDA clinical trials on our oral insulin candidate with this award-winning CRO."

CEO of global pharmaceutical company

Endocrine and Metabolic CRO for Clinical Research

With a successful track record of approvable NDA submissions, deep therapeutic expertise and more than 20 years of experience, Medpace successfully navigates the complexities and regulatory scrutiny of endocrine/metabolic development programs. We help our clients:

  • Proactively identify and avoid potential challenges for these often novel therapies
  • Design smart, efficient trials that are both cost-effective and addresses regulatory requirements for patient safety
  • Develop more accurate feasibility assessments and accelerate patient recruitment
  • Adjudicate clinical events or endpoints rapidly and efficiently

Deep and Broad Endocrine/Metabolic Experience

  • Since 1992, Medpace has conducted hundreds of endocrine/metabolic trials around the globe
  • Significant involvement in 20 NDA submissions
  • Large-scale multinational trial programs, including in emerging markets
  • Broad compound experience for Type 1 and Type 2 diabetes, major obesity programs, hypercholesterolemia, mixed dyslipidemia, and/or with very high triglycerides

Experience in difficult to recruit populations, including:

  • Narrow HbA1c criteria
  • Concomitant diseases (obesity, hypertension, metabolic disorders)
  • Metformin-only patients

The Medpace Difference for Endocrine-Metabolic Studies

In addition to the Medpace Difference that applies to all of our therapeutic areas, our endocrine-metabolic clients benefit from:
  • Medical and regulatory experts who have helped pioneer many preventative metabolic compounds.
  • Close working relationships with investigators, which leads to more accurate feasibility, better recruitment and improved retention.
  • Operational staff with proven track record of successful retention techniques, lifestyle education, and specific site issues
  • associated with diabetes and obesity trial management.
  • Medpace central labs, located in the U.S., Europe, China and Singapore, offering one of the most extensive selections of metabolic biomarkers for clinical trials.
  • Integrated ECG core lab and clinical pharmacology unit to streamline development.
  • Centralized clinical adjudication services, with electronic adjudication system for more rapid turnaround.